Table 4: Biochemical Data of the Participants in the Longitudinal Study (One Year of Follow-Up)
|
Δ BMI z-sc < 0,3 (n=43) |
Δ BMI z-sc ≥ 0,3 (n=17) |
| T1 |
T2 |
p |
T1 |
T2 |
p |
| Lipid
profile |
| TG (mmol/l) |
0.77 (0.50-1.02) |
0.65 (0.51-0.95) |
0.795 |
0.87 (0.64-1.30) |
0.63 (0.50-0.90) |
0.003 |
| Chol (mmol/l) |
3.93 (3.50-4.68) |
4.10 (3.51-4.50) |
0.929 |
4.24 (3.80-4.70) |
4.00 (3.58-4.24) |
0.009 |
| HDLc (mmol/l) |
1.14 (0.98-1.32) |
1.13 (0.93-1.31) |
0.960 |
1.13 (0.98-1.26) |
1.17 (0.92-1.32) |
0.819 |
| LDLc (mmol/l) |
2.59 (2.20-3.00) |
2.47 (2.21-2.90) |
0.534 |
2.69 (2.30-3.24) |
2.42 (2.06-2.69) |
0.007 |
| Lpa (mg/dl) |
19.0 (10.0-43.0) |
28.0 (12.6-48.6) |
0.011 |
22.0 (14.0-49.1) |
30.60 (8.29-51.55) |
0.403 |
| Apo A (mg/dl) |
118.5 ± 18.5 |
114.1 ± 18.0 |
0.052 |
118.3 ± 22.4 |
109.8 ± 17.4 |
0.060 |
| Apo B (mg/dl) |
75.9 ± 16.0 |
73.8 ± 17.2 |
0.498 |
79.8 ± 14.7 |
72.9 ± 14.1 |
0.013 |
| Chol/HDLc |
3.68 (3.17-4.16) |
3.60 (3.10-4.50) |
0.808 |
3.91 (3.34-4.24) |
3.50 (3.05-4.20) |
0.416 |
| Apo A/Apo B |
1.62 ± 0.40 |
1.60 ± 0.33 |
0.780 |
1.54 ± 0.44 |
1.55 ± 0.37 |
0.803 |
| Glucose
metabolism |
| Glucose (mmol/l) |
5.00 (4.83-5.22) |
4.80 (4.50-5.10) |
0.014 |
5.00 (4.64 - 5.28) |
4.57 (4.04-4.98) |
0.002 |
| Insulin (mmol/l) |
12.70 (9.50-15.70) |
11.40 (9.54-16.60) |
0.395 |
14.40 (11.60 - 17.80) |
10.90 (7.6-14.38) |
0.015 |
| HOMA |
2.80 (2.14-3.56) |
2.33 (1.82-3.31) |
0.255 |
3.01 (2.41 - 4.24) |
1.98 (1.51-2.89) |
0.007 |
|
Inflammatoy markers |
| Adiponectin (mg/l) |
8.58 (5.56-11.66) |
6.04 (4.74-9.13) |
0.004 |
9.28 (7.37 - 15.02) |
10.17 (6.63-14.22) |
0.675 |
| CRP (mg/l) |
1.61 (0.82-4.62) |
1.67 (0.78-4.12) |
0.402 |
0.94 (0.43 - 2.02) |
1.07 (0.54-2.38) |
0.213 |